This article provides a detailed, evidence-based analysis of the efficiency, precision, and practical applications of CRISPR-Cas9, TALEN, and ZFN genome editing platforms.
This article provides a critical, evidence-based comparison of off-target effects across the three primary genome editing platforms: CRISPR-Cas9, TALENs, and ZFNs.
This article provides a comprehensive guide for researchers and drug development professionals on implementing CRISPR-Cas9 gene editing in primary human cells.
This article provides a detailed, current guide to the CRISPR-Cas9 knockout mechanism for researchers and drug development professionals.
This comprehensive guide provides researchers, scientists, and drug development professionals with a complete workflow for generating CRISPR Cas9 knockout cell lines.
This guide provides a comprehensive framework for employing CRISPR-Cas9 in functional genomics, tailored for researchers and drug development professionals.
This article provides a comprehensive guide for researchers and drug development professionals on CRISPR-Cas12a-derived base editing systems for multiplexed genome engineering.
This article provides a detailed, current overview of lipid nanoparticle (LNP) delivery systems for next-generation CRISPR-Cas variants (e.g., Cas12, base editors, prime editors).
This article provides a comprehensive guide for researchers and drug development professionals on the CRISOT tool, a critical resource for CRISPR-Cas9 genome editing.
This article provides a detailed exploration of the CORRECT (COnsecutive Re-guideE RNA for CRISPR Tiling) method for scarless, marker-free genome editing.